Hosts lacking Fms-like tyrosine kinase 3 ligand exhibit marked reductions in transplant vascular sclerosis

Transplantation

Volumn 79, Issue 8, 2005, Pages 869-875

  Wang, Zhiliang ^a   Taner, Timuçin ^a,b   Morelli, Adrian E ^a   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cells; Flt3 ligand; Transplantation; Vascular sclerosis

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; ALPHA SMOOTH MUSCLE ACTIN; CD135 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; LIGAND; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ABDOMINAL AORTA; ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; AORTA GRAFT; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; BONE MARROW CELL; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROMUSCULAR DYSPLASIA; FLOW CYTOMETRY; GENE DISRUPTION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; AORTA; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; IMMUNOGLOBULIN G; INTERFERONS; ISOANTIBODIES; ISOANTIGENS; MALE; MEMBRANE PROTEINS; MICE; SCLEROSIS; T-LYMPHOCYTES; TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 17844401776     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000157120.43052.3A     Document Type: Article

References (25)

1. Tilney NL, Strom TB, Paul LC, eds. Transplantation biology: cellular and molecular aspects. Philadelphia, Lippincott-Raven Publishers 1996.
2. Libby P. Transplantation-associated arteriosclerosis: potential mechanisms. In: Tilney NL, Strom TB, Paul LC, eds. Transplantation biology: cellular and molecular aspects. Philadelphia, Lippencott-Raven 1996, p 577.
3. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767.
4. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21: 685.
5. Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982; 155: 31.
6. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med 1990; 171: 307.
7. Rastellini C, Lu L, Ricordi C, et al. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995; 60: 1366.
8. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996; 62: 659.
9. Maraskovsky E, Brasel K, Teepe M, et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med 1996; 184: 1953.
10. Coates PT, Barratt-Boyes SM, Zhang L, et al. Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand. Blood 2003; 102: 2513.
11. Maraskovsky E, Daro E, Roux E, et al. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 2000; 96: 878.
12. Steptoe RJ, Fu F, Li W, et al. Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. J Immunol 1997; 159: 5483.
13. +) dendritic cells: association with conversion from liver transplant tolerance to acute rejection. Transplantation 2000; 69: 2647.
14. McKenna HJ, Stocking KL, Miller RE, et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000; 95: 3489.
15. Wang Z, Castellaneta A, De Creus A, et al. Heart, but not skin allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time. J Immunol 2004; 172: 5924.
16. Morelli AE, Zahorchak AF, Larregina AT, et al. Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood 2001; 98: 1512.
17. Wang Z, Morelli AE, Hackstein H, et al. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb. Transplantation 2003; 76: 562.
18. Bobryshev YV, Lord RS. Langhans cells of human arterial intima: uniform by stellate appearance but different by nature. Tissue Cell 1996; 28: 177.
19. Waltner-Romen M, Falkensammer G, Rabl W, et al. A previously unrecognized site of local accumulation of mononuclear cells. The vascular-associated lymphoid tissue. J Histochem Cytochem 1998; 46: 1347.
20. Larsen CP, Steinman RM, Witmer-Pack M, et al. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990; 172: 1483.
21. Austyn JM. Dendritic cells in spleen and lymph node. In: Lotze MT, Thomson AW, eds. Dendritic cells: biology and clinical applications. San Diego, Academic Press 1999, p 179.
22. Pober JS, Collins T, Gimbrone MA, Jr, et al. Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation 1986; 41: 141.
23. Murray AG, Libby P, Pober JS. Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogeneic CD4+ T cell proliferation in vitro. J Immunol 1995; 154: 151.
24. Morelli AE, Thomson AW. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 2003; 196: 125.
25. Hackstein H, Thomson AW. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 2004; 4: 24.